Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 21, 2014
Pharmacy Choice - Pharmacy News - September 21, 2014

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
9/21/14 - Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at
Originally approved by the Food and Drug Administration in 1996, GSK's Flovent is a synthetic ICS therapy with potent anti-inflammatory activity. It is used for the maintenance treatment of asthma prophylactically in children and adults. Flovent is now available in two formulations, Diskus and HFA, which received the FDA approval in 2000 and 2004,.
9/20/14 - Esaote Secures FDA Clearance for MyLab Six Ultrasound System [Professional Services Close - Up]
Esaote North America recently reported that its new MyLab Six ultrasound system has received 510 clearance from the U.S. Food and Drug Administration and is now available for sale in the United States. According to a release from the company, MyLab Six is a compact ultrasound with a profile to improve ergonomics for sonographers scanning in a seate
9/20/14 - India,United States : FDA approves AUROBINDO PHARMA for Amoxicillin for Oral Suspension [TendersInfo (India)]
Aurobindo Pharma Ltd. has announced the obtaining of final approval from the US FDA to manufacture and market Amoxicillin for Oral Suspension USP 125 mg/5mL and 250 mg/5mL, covered under ANDA 204030.. This ANDA has been sanctioned out of Unit XII, Semi-Synthetic Penicillin formulation facility in Hyderabad, India. Now, Aurobindo has a total of 195
9/20/14 - RBCC Explores Naltrexone [Professional Services Close - Up]
From chronic pain to obesity, new research suggests that there are practically no limits to the number of illnesses that the prescription drug Naltrexone can treat. Biotech company Rainbow Coral Corp. is working to make Naltrexone more effective than ever before. According to a media release, for years, Naltrexone has been approved by the FDA to re
9/20/14 - United States : FDA approves Trulicity to treat type 2 diabetes [TendersInfo (India)]
The U.S. Food and Drug Administration today approved Trulicity, a once-weekly subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects about 26 million people and accounts for more than 90 percent of diabetes cases diagnosed in the United States. "Type 2 diabetes is a
9/19/14 - FDA Clears Siemens' SOMATOM Scope CT System
Release date- 18092014- Siemens Healthcare has announced that the Food and Drug Administration has cleared the SOMATOM Scope, a new 16- slice computed tomography scanner. Designed for private radiology practices, community hospitals, critical access hospitals, specialty practices such as orthopedics and urology, and veterinary medicine, the SOMATOM

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


The Diversion of Controlled Substances and the Law
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement